Primary Site >> Colorectal Cancer

Gene >> F10

  • 1985
  • 1990
  • 1991
  • 2009
  • 2010
  • 2011
  • 2012
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Tumor cell generation of thrombin via functional prothrombinase assembly.
PMID: 4053025
Ref: Correlation between the presence of microvilli and the growth or metastatic potential of tumor cells.
PMID: 1977729
Ref: Cellular localization of activated factor X by Xa-specific probes.
PMID: 1871716
Ref: Coagulation factor Xa inhibits cancer cell migration via protease-activated receptor-1 activation.
PMID: 19250659
Ref: [Prolonged prophylaxis of thromboembolic disease in patients with colorectal surgical resections for malignancy].
PMID: 20662445
Ref: Coagulation Factor Xa inhibits cancer cell migration via LIMK1-mediated cofilin inactivation.
PMID: 20347121
Ref: Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer.
PMID: 21103076
Ref: Efficacy of oral colon-specific delivery capsule of low-molecular-weight heparin on ulcerative colitis.
PMID: 21227626
Ref: Substrate optimization and clinical validation of reporter peptides for MS-based protease profiling in serum specimens: a new approach for diagnosis of malignant disease.
PMID: 21503574
Ref: Co-localization of Protein Z, Protein Z-Dependent protease inhibitor and coagulation factor X in human colon cancer tissue: implications for coagulation regulation on tumor cells.
PMID: 22424030
Ref: Rivaroxaban therapy resulting in the resolution of right atrial thrombosis resistant to ordinary control with warfarin in a patient with atrial fibrillation.
PMID: 25786449
Ref: Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients.
PMID: 27015840
Ref: Edoxaban Was Effective for the Treatment of Deep Vein Thrombosis and Pulmonary Thromboembolism in a Cancer Patient with Antithrombin III Deficiency.
PMID: 27853070
Ref: The interval approach: an adaptation of the liver-first approach to treat synchronous liver metastases from rectal cancer.
PMID: 28253875
Ref: Intratumoral injection of activated B lymphoblast in combination with PD-1 blockade induces systemic antitumor immunity with reduction of local and distal tumors.
PMID: 30221041